Not yet a member?
Hello everyone, I wanted to follow-up on Dr. West’s post about cancer survivorship a few days ago. The term “cancer survivorship” can mean lots of different things to different people. In this post, cancer survivors are those patients who finished their cancer treatment and are now being followed to see if their cancer [...]
4 CommentsContinuing on the issue of heparins potentially improving survival of cancer patients, other studies have suggested a survival benefit for low molecular weight heparin (LMWH) in cancer patients. The Malignancy and Low-Molecular-Weight Hepatin Therapy study (MALT, a bit of a stretch) by Klerk and colleagues (abstract here) enrolled 302 patients with [...]
0 CommentsIn a prior post we touched on some reasons why heparins, blood thinners that are given IV or under the skin (subcutaneously), may have direct anti-tumor effects that could improve cancer outcomes, and another post covered the mixed results with the oral anticoagulant (blood thinner) coumadin in cancer, most notably SCLC. [...]
0 CommentsAlthough in the last few years there has been a greater focus on low molecular weight heparins (LMWHs), which are injected, the oral anticoagulant (blood thinner) has been studied in this capacity and is certainly widely used in clinical practice for patients with blood clots due to its oral administration, which is [...]
0 Comments Blood clots are a common problem in cancer, including lung cancer, and several studies have shown that this contributes to diminished survival in cancer patients (abstract here):
(click to enlarge)
Once a blood clot has been detected, most typically a deep vein thrombosis (DVT) that is commonly detected in the leg, or a [...]